Predictive Oncology, Inc. (POAI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1240684,
    "name": "Predictive Oncology, Inc.",
    "stock_name": "Predictive Oncology, Inc.",
    "full_name": "Predictive Oncology, Inc.",
    "name_url": "stocks-analysis/predictive-oncology-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.47",
    "chg": -0.08,
    "chgp": "-1.35%",
    "dir": -1,
    "prev_price": "5.55",
    "mcapval": "10.47",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US74039M3097",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "102.2 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/predictive-oncology-inc-1240684-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Predictive Oncology, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-predictive-oncology-inc-technically-bullish-or-bearish-3546919",
        "imagepath": "",
        "date": "2025-09-20 19:43:03",
        "description": "As of 8 September 2025, the technical trend for Predictive Oncology, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the KST also shows mild bullishness in the same periods. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands present a bullish signal weekly but are mildly bearish monthly. The Dow Theory shows no trend on a weekly basis but is mildly bullish monthly. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.92% and 15.71% compared to 1.05% and 2.33% for the index, respectively. However, over longer periods, the stock has significantly underperformed the S&P 500, particularly over the 3-year and 5-year periods...."
      },
      {
        "title": "Is Predictive Oncology, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-predictive-oncology-inc-overvalued-or-undervalued-3543393",
        "imagepath": "",
        "date": "2025-09-20 18:18:11",
        "description": "As of 14 August 2018, the valuation grade for Predictive Oncology, Inc. moved from does not qualify to risky, indicating heightened concerns regarding its financial health. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -8.38, an EV to EBIT of -0.59, and an EV to EBITDA of -0.61. These figures suggest significant challenges in generating positive returns relative to its capital structure.\n\nIn comparison to its peers, Predictive Oncology's valuation ratios are notably weaker; for instance, Nutriband, Inc. has a much higher EV to EBITDA of -11.2912, while Nephros, Inc. boasts a strong P/E ratio of 31.3944, highlighting the disparity in financial performance within the sector. Despite a recent positive stock return of 20.39% year-to-date, which outperformed the S&P 500's 12.22%, the long-term performance remains concerning, with a staggering decl..."
      }
    ],
    "total": 7,
    "sid": "1240684",
    "stock_news_url": "https://www.marketsmojo.com/news/predictive-oncology-inc-1240684"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Predictive Oncology, Inc. technically bullish or bearish?

2025-09-20 19:43:03

As of 8 September 2025, the technical trend for Predictive Oncology, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the KST also shows mild bullishness in the same periods. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands present a bullish signal weekly but are mildly bearish monthly. The Dow Theory shows no trend on a weekly basis but is mildly bullish monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.92% and 15.71% compared to 1.05% and 2.33% for the index, respectively. However, over longer periods, the stock has significantly underperformed the S&P 500, particularly over the 3-year and 5-year periods....

Is Predictive Oncology, Inc. overvalued or undervalued?

2025-09-20 18:18:11

As of 14 August 2018, the valuation grade for Predictive Oncology, Inc. moved from does not qualify to risky, indicating heightened concerns regarding its financial health. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -8.38, an EV to EBIT of -0.59, and an EV to EBITDA of -0.61. These figures suggest significant challenges in generating positive returns relative to its capital structure. In comparison to its peers, Predictive Oncology's valuation ratios are notably weaker; for instance, Nutriband, Inc. has a much higher EV to EBITDA of -11.2912, while Nephros, Inc. boasts a strong P/E ratio of 31.3944, highlighting the disparity in financial performance within the sector. Despite a recent positive stock return of 20.39% year-to-date, which outperformed the S&P 500's 12.22%, the long-term performance remains concerning, with a staggering decl...

View All News